Program News
News and stories about members of the UNC Lineberger Molecular Therapeutics Research Program
-
Poor oral health could lessen survival from head and neck cancer
An international study has revealed strong associations between oral health and survival among people diagnosed with head and neck cancer.
-
NCI awards Pecot $1.8 million lung cancer research grant
The grant will support Chad Pecot, MD, and his research investigating the roles circular RNA may have in regulating whether a form of lung cancer will spread beyond the original cancer site.
-
American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
-
RNA discoveries drive oncologist’s next chapter
Physician-scientist and cancer survivor Chad Pecot, MD, is focused on RNA discoveries in the lab and the clinic.
-
Office of Graduate Education recognizes four Lineberger members with mentorship awards
The UNC School of Medicine Office of Graduate Education presented mentorship awards to four UNC Lineberger members, Jessica Bowser, PhD, Sharon Campbell, PhD, Charles Perou, PhD, and Will Valdar, PhD.
-
Lung Cancer Initiative awards Pecot $100,000 grant
The grant supports Chad Pecot, MD, and his research into the mechanistic and therapeutic implications of co-targeting two genes linked to lung cancer.
-
Devising a smarter way to treat brain tumors
Shawn Hingtgen, PhD, and his lab team have developed a method they call a “slice platform” that may help clinicians choose the best treatment for their brain tumor patients.
-
Getting to the heart of chemotherapeutic cardiotoxicity
Brian Jensen, MD, sees cancer patients who have developed, or are at risk of developing, heart damage in response to their chemotherapy regimens.
-
Lindsey James: Building a career, one molecule at a time
Lindsey James, PhD, is well-suited to the collaborative relationship between UNC Lineberger and UNC Eshelman School of Pharmacy, taking her interests in medicinal chemistry and epigenetics and working with cancer center physicians and researchers to make strides into cancer care and treatment.
-
UNC Lineberger and UNC researchers discuss latest research at American Society of Hematology Annual Meeting
UNC Lineberger researchers will present the latest findings from studies and lead educational sessions at the 64th American Society of Hematology Annual Meeting in New Orleans, Dec. 10-13.
-
UNC Lineberger faculty recognized as world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
-
UNC Lineberger creates RNA Discovery Center
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.
-
Implant churns out CAR-T cells to combat cancer in animal models
Yevgeny Brudno, PhD, and colleagues from NC State University and UNC-Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T for attacking cancerous tumors.
-
Four UNC Lineberger members elected AAAS fellows
Four UNC Lineberger members have been elected 2021 fellows of the American Association for the Advancement of Science, one of the most distinct honors in the scientific community.
-
New vulnerability found in lung squamous cancer may facilitate drug targeting at the cellular level
New research by Chad Pecot, MD, and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer.